tweenvest

Rafarma Pharmaceuticals, Inc. (OTCPK: RAFA)

Health Care · Health Care Equipment & Supplies · US

$0.01

-30.49% today · -73.4% 1Y

Public summary
A free snapshot of Rafarma Pharmaceuticals, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Rafarma Pharmaceuticals, Inc. (OTCPK: RAFA) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $728.47K and employs 700 people.

Over the last twelve months the share price has lost 73.4%, trading between 0.01 and 0.09.

Tweenvest scores Rafarma Pharmaceuticals, Inc. across four factors: quality 58/100, value 55/100. Its strongest factor is quality.

RAFA price history

Nov 20, 2025 · 0.03Weekly closes 0.01 – 0.08Nov 16, 2026 · 0.01

Key figures

Market cap
$728.47K
Revenue (TTM)
$133.33K
P/E
-6.21
EPS
-0.01
Dividend yield
—
Beta (5Y)
0.96
52-week high
$0.09
52-week low
$0.01
Avg volume (3M)
—
Shares outstanding
87.77M
Employees
700
Next earnings
—

About Rafarma Pharmaceuticals, Inc.

Rafarma Pharmaceuticals, Inc. is a diversified pharmaceutical enterprise that manufactures and distributes a range of medicinal products, including generic antibiotics and specialized drugs, within the Russian market. Its product portfolio encompasses anti-cancer medications, cephalosporin-derived compounds, and non-beta-lactam antibiotics. These are available in various formats such as injectable solutions, ampoules, pediatric suspensions, oral tablets, and capsules. Additionally, Rafarma develops and supplies treatments for injuries, ocular inflammatory conditions, and immunological ailments. In a collaborative effort with PlantEXT Ltd., the company is involved in the research and production of pioneering medical cannabis suppositories, specifically designed for individuals afflicted with inflammatory bowel disease. Originally incorporated as Johnston Acquisition Corp., the firm adopted its current name, Rafarma Pharmaceuticals, Inc., in October 2012. While headquartered in Sandy, Utah, its primary manufacturing and distribution operations are situated in Russia. Since October 19, 2020, Rafarma Pharmaceuticals, Inc. has functioned as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.

ISIN
US75062C1009
Founded
1982
Listed since
Dec 11, 2012
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
SpectraCure AB (publ)OM: SPEC$905.53KSkr0.02+6.00%
TSP Advanced Technologies PlcOFEX: TSP$891.61K£0.000.00%
Nu-Med Plus, Inc.OTCPK: NUMD$793.71K$0.01+11.76%
Odyssey Health, Inc.OTCPK: ODYY$761.61K$0.01-7.87%
Flyte Aviation, Inc.NYSEAM: VJET$637.56K$0.44-10.11%
Vivanza Biosciences LimitedBSE: 530057$602.41KRs1.42-4.05%
Electromedical Technologies, Inc.OTCPK: EMED$373.23K$0.000.00%
elexxion AGDB: E8X$371.83K€0.03-35.60%

Browse every Health Care Equipment & Supplies company →